Transmission Dynamics of Carbapenem Resistance in Enterobacter cloacae: Molecular Insights from Guangdong Province

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) are a mounting global health concern, with Enterobacter cloacae (CREC) identified as one of the most prevalent agents of multidrug-resistant infections in China. During the COVID-19 pandemic, increased antibiotic usage and interruptions in healthcare delivery may have accelerated the emergence and spread of resistance mechanisms, particularly those mediated by carbapenemase-encoding genes (CEGs). Despite CREC's clinical importance, comprehensive molecular epidemiological data on the characteristics and transmission of CEGs in CREC remain scarce, especially in the context of pandemic-altered healthcare environments. The study by Chen et al. addresses this gap by characterizing the prevalence, genetic location, and mobility of CEGs in CREC isolates from eight teaching hospitals in Guangdong Province between 2022 and 2024 (Chen et al., 2025).

Key Innovation from the Reference Study

The central innovation of this work lies in its dual focus: (1) mapping the precise distribution of CEGs—including blaNDM-1, blaIMP, and blaKPC-2—across both plasmid and chromosomal compartments of CREC, and (2) quantifying the efficiency of CEG transfer via horizontal gene transfer mechanisms. By integrating detailed genotyping (ERIC-PCR), mobile genetic element identification, and conjugation experiments, the study provides a multidimensional view of resistance gene dynamics during a period of heightened antibiotic pressure (Chen et al., 2025).

Methods and Experimental Design Insights

The study analyzed 54 CREC isolates collected over an 18-month period. Key methodological highlights include:

• Plasmid Elimination and PCR: Variable temperature SDS plasmid curing was used to distinguish chromosomal vs. plasmid CEG carriage. PCR screens identified the presence of key carbapenemase genes.
• Antimicrobial Susceptibility Testing: Broth microdilution assays assessed resistance to clinically relevant antibiotics, including gentamicin, imipenem, cefepime, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Conjugation Experiments: Mating assays quantified the efficiency of horizontal gene transfer for different CEGs.
• Mobile Genetic Element Profiling: Six distinct mobile genetic elements were mapped, with ISEcp1 being most prevalent.
• Genotyping: ERIC-PCR and NTSYS cluster analysis categorized the isolates into 17 genotypes, revealing patterns of intra- and inter-hospital spread.

Protocol Parameters

• assay | broth microdilution | 96-well format, CLSI standards | applicability: resistance profiling for Gram-negative bacterial infection model | rationale: enables high-resolution discrimination of multidrug resistance phenotypes in CREC | source: Chen et al., 2025
• assay | variable temperature SDS plasmid elimination | temperature ramping (37–42°C), SDS 0.1% | applicability: distinguishing chromosomal vs. plasmid gene carriage | rationale: critical for mapping mobility of antibiotic resistance determinants | source: Chen et al., 2025
• assay | ERIC-PCR genotyping | standardized primers, 30 cycles | applicability: strain typing and epidemiological tracing | rationale: facilitates understanding of CREC dissemination within and between hospitals | source: Chen et al., 2025
• assay | gentamicin susceptibility testing | 0.25–128 μg/mL | applicability: benchmarking aminoglycoside antibiotic resistance in CREC | rationale: essential for monitoring clinical and laboratory resistance trends | source: Chen et al., 2025
• assay | mobile genetic element PCR mapping | multiplex PCR, 6 target elements | applicability: evaluating potential for horizontal gene transfer | rationale: identifies vehicles for CEG dissemination | source: Chen et al., 2025

Core Findings and Why They Matter

Key results from the study include:

• High Prevalence of CEGs: 85.19% of isolates carried at least one carbapenemase-encoding gene (Chen et al., 2025).
• Distribution: blaNDM-1 was the dominant gene, found either on both chromosomes and plasmids (33.33%) or exclusively on plasmids (46.30%). Minor fractions carried blaIMP or a combination of blaNDM-1 and blaKPC-2.
• Resistance Profiles: CEG-positive isolates exhibited significantly higher resistance to multiple antibiotics, including gentamicin, compared to CEG-negative strains (P<0.05) (Chen et al., 2025).
• Transferability: Conjugation experiments demonstrated a 95.65% success rate for CEG transfer, underscoring the high potential for horizontal gene transmission.
• Mobile Elements: ISEcp1 was the most common mobile genetic element (87.04% of strains), and co-occurrence of multiple elements was frequent, increasing the potential for gene mobilization.
• Epidemiological Patterns: Higher detection rates were observed in male and elderly patients, within respiratory departments, and in sputum samples.

These findings highlight the dual threat of stable chromosomal resistance and highly mobile plasmid-borne genes, which together facilitate both vertical and horizontal dissemination of carbapenem resistance in clinical settings. The rapid transferability of blaNDM-1, in particular, presents a significant challenge for infection control and antibiotic stewardship efforts.

Comparison with Existing Internal Articles

The present study's focus on resistance gene mobility and phenotypic resistance profiles aligns with themes addressed in several recent internal resources. For instance, "Gentamycin Sulfate: Precision Tool for Ribosome-Targeted Research" (internal article) explores how aminoglycoside antibiotics are used to interrogate ribosome function and model resistance development, which is directly relevant given the observed gentamicin resistance among CEG-positive CREC. Additionally, "Gentamycin Sulfate in Translational Research: Mechanistic..." (internal article) discusses the utility of research-grade aminoglycoside antibiotics in dissecting bacterial protein synthesis and resistance—paralleling the current study’s use of susceptibility profiling to map resistance landscapes. The present findings reinforce the importance of robust bacterial protein synthesis research and study of antibiotic resistance mechanisms in the context of rapidly evolving multidrug resistance.

Limitations and Transferability

While this study provides a comprehensive snapshot of CEG epidemiology in Guangdong teaching hospitals, several limitations should be noted. First, the sample size, although spanning eight hospitals, is relatively modest and may not capture the full genetic diversity or rare resistance mechanisms present in the broader region. Second, the study period coincides with the COVID-19 pandemic, which may have influenced both resistance patterns and detection rates due to altered clinical practices. Finally, while conjugation experiments demonstrate high transferability in vitro, real-world dissemination may be modulated by additional ecological or host factors. Nonetheless, the mechanistic insights into CEG mobilization and resistance phenotypes are broadly transferable to other Gram-negative bacterial infection models and can inform future surveillance, infection control, and research strategies.

Research Support Resources

Researchers aiming to replicate or extend these workflows in bacterial protein synthesis research or ribosome function analysis can employ well-characterized aminoglycoside antibiotics as experimental benchmarks. Gentamycin Sulfate (SKU A2514) from APExBIO, a broad-spectrum aminoglycoside antibiotic with high water solubility and defined purity, is suitable for use in resistance profiling, functional ribosome assays, and studies of antibiotic resistance mechanisms. For protocol optimization and application-specific guidance, consult product documentation and relevant workflow recommendations.